ANNX FY 2024 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$713M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$154M

Net Income

-$138M

EPS (Diluted)

$-1.01

Cash Flow

Operating Cash Flow

-$118M

Free Cash Flow

-$118M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$350M

Total Liabilities

$57M

Stockholders' Equity

$293M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	$0	—
Operating Income	-$154M	-$144M	-7.2%
Net Income	-$138M	-$134M	-3.0%